Physician profile
Amy E Baker
NPI 1811377377
$1,664.92
in general payments reported to CMS, 2019-2025
24 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $14.93 · 2021: $449 · 2022: $195 · 2023: $376 · 2024: $182 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $381.11 | 2021-2023 | Ova1 |
| Exeltis, USA INC. | $288.26 | 2021-2025 | Slynd |
| Minerva Surgical, INC | $125.96 | 2021-2025 | |
| Abbvie INC. | $122.93 | 2019 | |
| Pfizer INC. | $104.37 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $77.38 | 2023-2025 | Myfembree |
| Celgene Corporation | $76.98 | 2025 | Reblozyl |
| Mayne Pharma Commercial LLC | $67.76 | 2023-2025 | |
| Channel Medsystems, INC. | $43.31 | 2022 | |
| Kite Pharma, INC. | $42.67 | 2020-2022 | |
| Hologic Sales and Service, LLC | $42.22 | 2025 | Aptima, Thinprep 2000 Processor |
| Astellas Pharma US INC | $34.23 | 2024-2025 | Veozah, Myrbetriq |
| Myovant Sciences INC. | $34.18 | 2022 | |
| Exact Sciences Corporation | $31.12 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $30.64 | 2023-2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $26.67 | 2024 | Gelpoint V-Path |
| Urogen Pharma, INC. | $23.65 | 2025 | |
| Glaxosmithkline, LLC. | $19.76 | 2022 | |
| Boston Scientific Corporation | $18.93 | 2025 | Axonics |
| Mirati Therapeutics, INC. | $15.97 | 2023 | Krazati |
| Millicent US INC | $15.29 | 2025 | Intrarosa |
| Medicem INC. | $14.38 | 2022 | |
| Gynesonics, INC. | $13.98 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Agile Therapeutics, INC. | $13.17 | 2023 | Twirla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.